Print Page     Close Window     

SEC Filings

10-Q
BIOTIME INC filed this Form 10-Q on 08/09/2017
Entire Document
 

7.3.
If required under Israel law, the Company shall [ * ] to any payments made under this Agreement to Hadasit. Any payment shall be made against the provision of tax invoice by Hadasit.

7.4.
Other than as set forth in the Budget, Hadasit shall not be entitled to any other payment, remuneration or consideration of any type from the Company for the performance of the Work and/or under this Agreement. For the avoidance of doubt, neither [ * ] nor any other member of his team is entitled to any consideration whatsoever directly from the Company in respect of the Work and/or under this Agreement and Hadasit shall be solely responsible for any consideration due to them for their involvement in the performance of the Work including but not limited to any salary, social benefits or severance pay.

7.5.
Hadasit shall be solely responsible for the payment of [ * ] required by applicable law to be made in connection with this Agreement. The Company shall [ * ], as prescribed by applicable law, unless Hadasit provides the Company with [ * ].

8.
PROPRIETARY RIGHTS

The provisions of Section 8 of the License Agreement shall govern with respect to Intellectual Property and other proprietary rights.

9.
CONFIDENTIAL INFORMATION AND PUBLICATIONS

9.1.
The provisions of Section 11 of the License Amendment shall govern with respect to Confidential Information and publications.

9.2.
Upon the written demand of the Company, Hadasit and [ * ] shall immediately return to the Company, at the [ * ] expense, all the materials, samples, graphics, writings and information in other tangible forms, containing any proprietary and/or Confidential Information provided by and belonging to the Company pursuant to this Agreement, and any copies of such information, provided that Hadasit shall be entitled to retain one copy for its records with its legal counsel.

10.
INDEMNIFICATION, INSURANCE, LIMITED LIABILITIES

 
10.1.
Indemnification. The Company shall defend, indemnify and hold harmless [ * ], Hadasit, HMO, the  Research Fund of the Hadassah Medical Organization and any of their employees, agents or contractors (collectively the "Indemnitees") promptly upon their first demand from and against [ * ]; provided, however:
 
[ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
 
- 50 -

© Copyright BioTime, Inc.